Literature DB >> 3488968

The immune system during the pre-cancer and the early cancer period. IL-2 production by PBL from post-menopausal women with and without endometrial carcinoma.

I Yron, M Schickler, B Fisch, H Pinkas, J Ovadia, I P Witz.   

Abstract

We report on alterations in IL-2 production and cell proliferation following PHA stimulation of peripheral blood lymphocytes (PBL) from stage-I endometrial carcinoma (EC) patients, and on mechanisms involved in these alterations. Our study includes 3 groups: EC patients, post-menopausal women at high risk of developing EC, and age-matched healthy women. IL-2 production was markedly lower in most EC patients than in healthy controls. Varying levels of IL-2 were produced by PBL from women in the high-risk group. The proliferative response of PBL to PHA appeared to correlate with levels of IL-2 production. Our results suggest that macrophages are involved, in part, in the modulation of T-cell functions of EC patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488968     DOI: 10.1002/ijc.2910380306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  CD5+ B cells and naturally occurring autoantibodies in cancer patients.

Authors:  R Stein; I P Witz; J Ovadia; D M Goldenberg; I Yron
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

2.  Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.

Authors:  Y Kikuchi; T Kita; K Oomori; M Miyauchi; I Iwano; I Kizawa
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

3.  A human monoclonal IgA autoantibody--185/12--behaves like an autoimmune antiphospholipid antibody.

Authors:  I Yron; L Shohat; J Lahav; I P Witz; B Fisch
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 4.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

5.  Plasma glutamate concentration and lymphocyte activity.

Authors:  W Dröge; H P Eck; M Betzler; P Schlag; P Drings; W Ebert
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.

Authors:  U Elsässer-Beile; S von Kleist; W Sauther; H Gallati; J S Mönting
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

7.  Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy.

Authors:  Y Kikuchi; I Kizawa; K Oomori; I Iwano; T Kita; K Kato
Journal:  Jpn J Cancer Res       Date:  1988-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.